UK markets close in 6 hours 31 minutes

NGM Biopharmaceuticals Inc (0IK.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
1.44000.0000 (0.00%)
As of 08:30PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
4,417
4,417
55,333
77,882
87,368
-
Operating expenses
Research development
118,040
118,040
181,067
161,712
163,972
-
Selling general and administrative
37,840
37,840
40,515
36,865
27,229
-
Total operating expenses
155,880
155,880
221,582
198,577
191,201
-
Operating income or loss
-151,463
-151,463
-166,249
-120,695
-103,833
-
Total other income/expenses net
-234
-234
-132
-60
-593
-
Income before tax
-142,375
-142,375
-162,667
-120,335
-102,487
-
Income tax expense
-
-
-
-
-
0
Income from continuing operations
-142,375
-142,375
-162,667
-120,335
-102,487
-
Net income
-142,375
-142,375
-162,667
-120,335
-102,487
-
Net income available to common shareholders
-142,375
-142,375
-162,667
-120,335
-102,487
-
Basic EPS
-1.83
-1.73
-2.03
-1.56
-1.50
-
Diluted EPS
-1.83
-1.73
-2.03
-1.56
-1.50
-
Basic average shares
82,247
82,496
79,950
77,085
68,475
-
Diluted average shares
82,247
82,496
79,950
77,085
68,475
-